NMR solution structure of the angiostatic peptide anginex

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 5, 2007, Pages 645-651

  Arroyo, Monica M ^a   Mayo, Kevin H ^a  

^a University of Minnesota   (United States)

Author keywords

Anti angiogenic; Anti bacterial; Conformation; Drug design

Indexed keywords

ANGINEX; ANGIOGENESIS INHIBITOR; ANGIOSTATIC PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BETA SHEET; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS);

EID: 34247581863     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.03.007     Document Type: Article

References (32)

1. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1-18
2. Carmeliet P. Angiogenesis in life, disease, and medicine. Nature 438 (2005) 932-936
3. Folkman J. Endogenous angiogenesis inhibitors. APMIS 112 (2004) 496-507
4. Folkman J. Angiogenesis inhibitors: a new class of drugs. Cancer Biol. Ther. 2 (2003) 127-133
5. Folkman J. Antiangiogenesis in cancer therapy-Endostatin and its mechanism of action. Exp. Cell Res. 312 (2006) 594-607
6. Verhoef C., de Wilt J.H., and Verheul H.M. Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology. Curr. Pharm. Des. 12 (2006) 2623-2630
7. Dings R.P., Nesmelova I., Griffioen A.W., and Mayo K.H. Discovery and development of anti-angiogenic peptides: a structural link. Angiogenesis 6 (2003) 83-91
8. Gupta S.K., and Singh J.P. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J. Cell Biol. 127 (1994) 1121-1127
9. Rastinejad F., Polverini P.J., and Bouck N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56 (1989) 345-355
10. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
11. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
12. van der Schaft D.W., Toebes E.A., Haseman J.R., Mayo K.H., and Griffioen A.W. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood 96 (2000) 176-181
13. Mayo K.H., Ilyina E., and Park H. A recipe for designing water-soluble, β-sheet-forming peptides. Protein Sci. 5 (1996) 1301-1315
14. Mayo K.H., Haseman J., Ilyina E., and Gray B. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities. Biochim. Biophys. Acta 1425 (1998) 81-92
15. Griffioen A.W., van der Schaft D.W., Barendsz-Janson A.F., Cox A., Struijker Boudier H.A., Hillen H.F., and Mayo K.H. Anginex, a designed peptide that inhibits angiogenesis. Biochem. J. 354 (2001) 233-242
16. Mayo K.H., and Griffioen A.W. Designing βpep peptides: a rational approach to the discovery of novel pharmaceutical agents and small molecules. Drugs Future 28 (2003) 337-346
17. Dings R.P.M., Yokoyama Y., Ramakrishnan S., Griffioen A.W., and Mayo K.H. The designed angiostatic peptide anginex synergistically improves chemotherapy and anti-angiogenesis therapy with angiostatin. Cancer Res. 63 (2003) 382-385
18. Dings R.P.M., Hargittai B., Haseman J., Griffioen A.W., and Mayo K.H. Anti-tumor activity of the novel angiogenesis inhibitor anginex. Cancer Lett. 194 (2003) 55-66
19. Thijssen V.L.J.L., Postel R., Brandwijk R.J.M.G.E., Dings R.P.M., Nesmelova I., Satijn S., Nakabeppu Y., Bakkers Baum.L.G., Mayo J., Poirier K.H., and Griffioen F. Galectin-1 is essential in tumor angiogenesis and is a target for anti-angiogenesis therapy. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15975-15980
20. Akerman M.E., Pilch J., Peters D., and Ruoslahti E. Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2040-2045
21. Mayo K.H., van der Schaft D.W., and Griffioen A.W. Designed β-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells. Angiogenesis 4 (2001) 45-51
22. Ilyina E., Roongta V., and Mayo K.H. NMR structure of a de novo designed, peptide 33mer with two distinct, compact β-sheet folds. Biochemistry 36 (1997) 5245-5250
23. Lockwood N.A., and Mayo K.H. The future of antibiotics: bacterial membrane disintegrators. Drugs Future 28 (2003) 911-923
24. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
25. Brunger A.T. X-plor Manual (1992), Yale University Press, New Haven
26. Mayo K.H., Haseman J., Young H.C., and Mayo J.W. Structure-function relationships in novel peptide dodecamers with broad-spectrum bactericidal and endotoxin-neutralizing activities. Biochem. J. 349 (2000) 717-728
27. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14 51-5 (1996) 29-32
28. Wüthrich K. NMR of Proteins and Nucleic Acids (1986), John Wiley and Sons, Inc., New York
29. Cavanagh J., Fairbrother W.J., Palmer I.I.I., and Skelton A.G. Protein NMR Spectroscopy: Principles and Practice (1996), Academic Press, San Diego
30. Wishart D.S., Sykes B.D., and Richards F.M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31 (1992) 1647-1651
31. Mayo K.H., Dings R.P.M., Flader C., Hargittai B., van Eijk L.I., Walek D., Haseman J., Hoye T.R., and Griffioen A.W. Design of a partial-peptide mimetic of anginex with antiangiogenic and anticancer activity. J. Biol. Chem. 278 (2003) 45746-45752
32. Dings R.P.M., Chen X., Hellebrekers D.M.E.I., van Eijk L.I., Zhang Y., Hoye T.R., Griffioen A.W., and Mayo K.H. Design of nonpeptide topomimetics of antiangiogenic proteins with antitumor activities. J. Natl. Cancer Inst. 98 (2006) 932-936